29
Views
22
CrossRef citations to date
0
Altmetric
Article

Lipoprotein lipase during heparin infusion: lower activity in hemodialysis patients

, , &
Pages 45-54 | Received 20 Jun 2002, Accepted 13 Dec 2002, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Dana Mahmood, Solveig Nilsson, Gunilla Olivecrona & Bernd Stegmayr. (2014) Lipoprotein lipase activity is favoured by peritoneal dialysis compared to hemodialysis. Scandinavian Journal of Clinical and Laboratory Investigation 74:4, pages 296-300.
Read now

Articles from other publishers (21)

Bernd Stegmayr, Li Zuo & Ward Zadora. (2024) Lipid and Bone Effects of Heparin Use During Hemodialysis. Seminars in Nephrology, pages 151480.
Crossref
Denis Kalugin, Jumanah Bahig, Ahmed Shoker & Amira Abdelrasoul. (2023) Heparin-Immobilized Polyethersulfone for Hemocompatibility Enhancement of Dialysis Membrane: In Situ Synchrotron Imaging, Experimental, and Ex Vivo Studies. Membranes 13:8, pages 718.
Crossref
Bilal Bashir, Jan H. Ho, Paul Downie, Paul Hamilton, Gordon Ferns, Dev Datta, Jaimini Cegla, Anthony S. Wierzbicki, Charlotte Dawson, Fiona Jenkinson, Hannah Delaney, Michael Mansfield, Yee Teoh, Zosia Miedzybrodzka, Haya Haso, Paul N. Durrington & Handrean Soran. (2023) Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome—Causes, Clinical Presentation, and Therapeutic Options. Metabolites 13:5, pages 621.
Crossref
Rasha Aly, Ratna Acharya & Kiran K. Upadhyay. (2022) Severe hypertriglyceridemia in an infant on chronic hemodialysis. Hemodialysis International 27:1.
Crossref
Carlo Maria Barbagallo, Angelo Baldassare Cefalù, Antonina Giammanco, Davide Noto, Rosalia Caldarella, Marcello Ciaccio, Maurizio Rocco Averna & Emilio Nardi. (2021) Lipoprotein Abnormalities in Chronic Kidney Disease and Renal Transplantation. Life 11:4, pages 315.
Crossref
Kelvin Cheuk-Wai Leung & Jennifer Marie MacRae. (2019) Anticoagulation in CKD and ESRD. Journal of Nephrology 32:5, pages 719-731.
Crossref
Hamid Moradi & Nosratola D. Vaziri. 2019. Endocrine Disorders in Kidney Disease. Endocrine Disorders in Kidney Disease 153 169 .
Bernd Stegmayr. (2017) Dialysis Procedures Alter Metabolic Conditions. Nutrients 9:6, pages 548.
Crossref
Kelvin C. W. Leung, Davina J. Tai, Pietro Ravani, Rob R. Quinn, Nairne Scott‐Douglas & Jennifer M. MacRae. (2016) Citrate vs. acetate dialysate on intradialytic heparin dose: A double blind randomized crossover study. Hemodialysis International 20:4, pages 537-547.
Crossref
Davina J. Tai, Kelvin Leung, Pietro Ravani, Robert R. Quinn, Nairne Scott-Douglas & Jennifer M. MacRae. (2015) The effect of citrate dialysate on intradialytic heparin dose in haemodialysis patients: study design of a randomised controlled trial. BMC Nephrology 16:1.
Crossref
Michael Holzer, Gernot Schilcher, Sanja Curcic, Markus Trieb, Senka Ljubojevic, Tatjana Stojakovic, Hubert Scharnagl, Chantal M. Kopecky, Alexander R. Rosenkranz, Akos Heinemann & Gunther Marsche. (2015) Dialysis Modalities and HDL Composition and Function. Journal of the American Society of Nephrology 26:9, pages 2267-2276.
Crossref
Carlo M. Barbagallo, Davide Noto, Angelo B. Cefalù, Antonia Ganci, Carlo Giammarresi, Donata Panno, Gaspare Cusumano, Massimiliano Greco, Francesca Di Gaudio & Maurizio R. Averna. (2014) Heparin induces an accumulation of atherogenic lipoproteins during hemodialysis in normolipidemic end‐stage renal disease patients. Hemodialysis International 19:3, pages 360-367.
Crossref
R. La Spina, C. Tripisciano, T. Mecca, F. Cunsolo, V. Weber & B. Mattiasson. (2014) Chemically modified poly(2‐hydroxyethyl methacrylate) cryogel for the adsorption of heparin. Journal of Biomedical Materials Research Part B: Applied Biomaterials 102:6, pages 1207-1216.
Crossref
Bernd Stegmayr. (2014) Uremic Toxins and Lipases in Haemodialysis: A Process of Repeated Metabolic Starvation. Toxins 6:5, pages 1505-1511.
Crossref
William F Keane, Joanne E Tomassini & David R Neff. (2013) Lipid Abnormalities in Patients with Chronic Kidney Disease: Implications for the Pathophysiology of Atherosclerosis. Journal of Atherosclerosis and Thrombosis 20:2, pages 123-133.
Crossref
Jenny I. Shen & Wolfgang C. Winkelmayer. (2012) Use and Safety of Unfractionated Heparin for Anticoagulation During Maintenance Hemodialysis. American Journal of Kidney Diseases 60:3, pages 473-486.
Crossref
Bernd Stegmayr, Thomas Olivecrona & Gunilla Olivecrona. (2009) PROGRESS IN UREMIC TOXIN RESEARCH: Lipoprotein Lipase Disturbances Induced by Uremia and Hemodialysis. Seminars in Dialysis 22:4, pages 442-444.
Crossref
G. Dautin, Z. Soltani, D. Ducloux, T. Gautier, J.P. Pais de Barros, P. Gambert, L. Lagrost & D. Masson. (2007) Hemodialysis reduces plasma apolipoprotein C-I concentration making VLDL a better substrate for lipoprotein lipase. Kidney International 72:7, pages 871-878.
Crossref
Konstantinos P. Katopodis, Elli Koliousi, Chariklia Gouva, Olga Balafa, Eleni Bairaktari, Margarita Ikonomou, Moses S. Elisaf & Kostas C. Siamopoulos. (2007) Acute Effect of Heparin on Lipid Parameters in Patients on Renal Replacement Therapy. ASAIO Journal 53:1, pages 46-49.
Crossref
Birgit Näsström, Bernd Stegmayr, Jitendra Gupta, Gunilla Olivecrona & Thomas Olivecrona. (2005) A single bolus of a low molecular weight heparin to patients on haemodialysis depletes lipoprotein lipase stores and retards triglyceride clearing. Nephrology Dialysis Transplantation 20:6, pages 1172-1179.
Crossref
Birgit Näsström, Bernd Stegmayr, Gunilla Olivecrona & Thomas Olivecrona. (2004) Lipoprotein lipase in hemodialysis patients: indications that low molecular weight heparin depletes functional stores, despite low plasma levels of the enzyme. BMC Nephrology 5:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.